A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine.
about
The establishment of surrogates and correlates of protection: Useful tools for the licensure of effective influenza vaccines?Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018.A complex epistatic network limits the mutational reversibility in the influenza hemagglutinin receptor-binding site."Gnothi Seauton": Leveraging the Host Response to Improve Influenza Virus Vaccine Efficacy.New Kids on the Block: RNA-Based Influenza Virus Vaccines.Epidemiological Studies to Support the Development of Next Generation Influenza Vaccines.Prediction of influenza vaccine effectiveness for the influenza season 2017/18 in the US.Low population serum microneutralization antibody titer against the predominating influenza A(H3N2) N121K virus during the severe influenza summer peak of Hong Kong in 2017.H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation.Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine.Viral Entry Properties Required for Fitness in Humans Are Lost through Rapid Genomic Change during Viral Isolation.Structural analyses reveal the mechanism of inhibition of influenza virus NS1 by two antiviral compoundsDeep mutational scanning of hemagglutinin helps predict evolutionary fates of human H3N2 influenza variantsMulti-clade H5N1 virus-like particles: Immunogenicity and protection against H5N1 virus and effects of beta-propiolactoneNucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodiesOligomerization of bacterially expressed H1N1 recombinant hemagglutinin contributes to protection against viral challenge
P2860
Q47564262-5D6AA39C-DE37-48C9-86E2-F9C17C317BA1Q49981002-DF900D45-F730-4749-A2A2-733464DD0C1AQ52338900-F2997AC7-47A7-47EC-84BC-63BC20E87274Q52381548-CF5C2063-124A-429F-9659-05391A86E7A5Q52609655-52C28E44-C82B-4AF8-AB26-EF6B024E3E74Q52627557-A3D5B927-AFE2-40FE-93A7-9770BF4452F0Q52657064-1B484EF6-E9FE-49F7-97B0-BC8C9EDD85A2Q52671135-032E607A-279B-4BF9-8529-05CB743293CDQ54237872-61A1606C-A89E-4E3D-B86B-B41FF4688E10Q54247364-56D8D7A6-2252-42A3-B925-DE5E0B387D09Q55442083-C6AE81F6-547F-4CD9-871F-08275A8C8791Q56535644-324CCC8A-E305-4B46-836D-3B8C81F7EDCFQ56888351-E018C77E-5118-464D-BAD6-5AF3747EAB03Q57094327-4BEEA028-10C0-481B-BE75-E15F1ED75DF4Q58721961-E77CE2EA-AC0F-4ED4-BB6C-A0C92F380952Q58797890-0AD3494F-9B51-4CBF-B6E7-32B9ED39FA58
P2860
A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A structural explanation for t ...... asonal influenza H3N2 vaccine.
@en
A structural explanation for t ...... asonal influenza H3N2 vaccine.
@nl
type
label
A structural explanation for t ...... asonal influenza H3N2 vaccine.
@en
A structural explanation for t ...... asonal influenza H3N2 vaccine.
@nl
prefLabel
A structural explanation for t ...... asonal influenza H3N2 vaccine.
@en
A structural explanation for t ...... asonal influenza H3N2 vaccine.
@nl
P2093
P2860
P50
P1433
P1476
A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine
@en
P2093
Corwin M Nycholat
Ian A Wilson
James C Paulson
P2860
P304
P356
10.1371/JOURNAL.PPAT.1006682
P577
2017-10-23T00:00:00Z